|
🐢
|
The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.
12 auth.
R. Belshe,
P. Mendelman,
J. Treanor,
J. King,
W. Gruber,
P. Piedra,
...
D. I. Bernstein,
F. Hayden,
K. Kotloff,
K. Zangwill,
D. Iacuzio,
M. Wolff
|
9 |
1998 |
9
🐢
|
|
🐢
|
Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.
J. Treanor,
J. Campbell,
K. Zangwill,
T. Rowe,
M. Wolff
|
9 |
2006 |
9
🐢
|
|
🐢
|
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine.
17 auth.
R. Belshe,
W. Gruber,
P. Mendelman,
I. Cho,
K. Reisinger,
S. Block,
J. Wittes,
D. Iacuzio,
P. Piedra,
J. Treanor,
...
J. King,
K. Kotloff,
D. I. Bernstein,
F. Hayden,
K. Zangwill,
Lihan K. Yan,
M. Wolff
|
8 |
2000 |
8
🐢
|
|
🐢
|
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.
16 auth.
R. Belshe,
W. Gruber,
P. Mendelman,
H. Mehta,
K. Mahmood,
K. Reisinger,
J. Treanor,
K. Zangwill,
F. Hayden,
David I. Bernstein,
...
K. Kotloff,
J. King,
P. Piedra,
S. Block,
Lihan K. Yan,
M. Wolff
|
8 |
2000 |
8
🐢
|
|
🐜
|
Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.
10 auth.
J. Treanor,
Bethanie E. Wilkinson,
Feda Masseoud,
Jean Hu-Primmer,
Rosalyn Battaglia,
D. O'Brien,
...
M. Wolff,
G. Rabinovich,
W. Blackwelder,
J. Katz
|
8 |
2001 |
8
🐜
|
|
🐜
|
The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.
22 auth.
M. Santosham,
M. Wolff,
R. Reid,
M. Hohenboken,
M. Bateman,
J. Goepp,
M. Cortese,
D. Sack,
Janne Hill,
W. Newcomer,
...
L. Capriotti,
Jeanne Smith,
Marjorie Owen,
S. Gahagan,
D. Hu,
Renee Kling,
L. Lukacs,
R. Ellis,
P. Vella,
G. Calandra,
H. Matthews,
V. Ahonkhai
|
8 |
1991 |
8
🐜
|
|
🐜
|
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults.
16 auth.
S. Frey,
M. Houghton,
S. Coates,
S. Abrignani,
D. Chien,
D. Rosa,
P. Pileri,
R. Ray,
A. D. Di Bisceglie,
P. Rinella,
...
H. Hill,
M. Wolff,
V. Schultze,
Jang-Hyuck Han,
B. Scharschmidt,
R. Belshe
|
7 |
2010 |
7
🐜
|
|
🐜
|
Clinical responses to undiluted and diluted smallpox vaccine.
10 auth.
S. Frey,
R. Couch,
C. Tacket,
J. Treanor,
M. Wolff,
F. Newman,
...
R. Atmar,
R. Edelman,
Carrie Nolan,
R. Belshe
|
7 |
2002 |
7
🐜
|
|
🐜
|
A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers.
15 auth.
Thomas G. Evans,
M. Keefer,
K. Weinhold,
M. Wolff,
D. Montefiori,
G. Gorse,
B. Graham,
M. McElrath,
M. L. Clements-Mann,
M. Mulligan,
...
P. Fast,
M. C. Walker,
J. Excler,
A. Duliege,
J. Tartaglia
|
7 |
1999 |
7
🐜
|
|
🐜
|
Dose-related effects of smallpox vaccine.
11 auth.
S. Frey,
F. Newman,
J. Cruz,
W. B. Shelton,
Janice M Tennant,
Tamara Polach,
...
A. Rothman,
J. Kennedy,
M. Wolff,
R. Belshe,
Francis A. Ennis
|
7 |
2002 |
7
🐜
|
|
🐬
|
High incidence rates of invasive pneumococcal disease in the White Mountain Apache population.
M. Cortese,
M. Wolff,
J. Almeido-Hill,
R. Reid,
J. Ketcham,
M. Santosham
|
7 |
1992 |
7
🐬
|
|
🐜
|
First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001).
32 auth.
Lindsey R Baden,
Lindsey R Baden,
Lindsey R Baden,
S. Walsh,
S. Walsh,
Michael S. Seaman,
M. Seaman,
Robert Tucker,
K. Krause,
Alka Patel,
Jennifer E. Johnson,
Jennifer E. Johnson,
J. Kleinjan,
Katherine E. Yanosick,
J. Perry,
...
Elise Zablowsky,
P. Abbink,
Lauren Peter,
M. Iampietro,
A. Cheung,
M. Pau,
M. Weijtens,
J. Goudsmit,
E. Swann,
M. Wolff,
H. Loblein,
R. Dolin,
R. Dolin,
R. Dolin,
D. Barouch,
D. Barouch,
D. Barouch
|
7 |
2013 |
7
🐜
|
